Qteros Appoints Recognized Industrial Biotechnology Leader, Christopher Dale, Ph.D., to Newly Created Position of Vice President, Research and Development

MARLBOROUGH, Mass., Jan. 10, 2011 /PRNewswire-USNewswire/ -- Qteros, Inc., the developer of a unique and highly efficient Consolidated Bioprocessing (CBP) platform for the lowest-cost production of cellulosic ethanol, today announced the appointment of Christopher J. Dale, Ph.D., to the newly created position of Vice President, Research and Development (R&D). A highly accomplished scientist, bacterial microbiologist and recognized leader in the industrial biotechnology industry, Dr. Dale brings close to three decades of broad and commercially oriented R&D experience focused on creating and implementing process development, process validation and manufacturing solutions for novel, industrial-scale biological applications.

John A. McCarthy, Jr., Qteros President & CEO commented, "Chris Dale is an excellent addition to the senior management team as we rapidly advance our technology platform for commercial-scale introduction. The breadth of his scientific, manufacturing and corporate leadership experience makes him ideally suited to help us accelerate our commercial development plans. Chris' proven service-oriented approach to partnership management combined with his expertise managing bio-industrial technology project lifecycles from concept to commercialization will be invaluable as we embark upon our newly formed partnership with Praj and contemplate additional strategic partnering opportunities ahead."

Dr. Dale joins Qteros with a successful track record of managing research, development and manufacturing processes from concept and early-stage development to large-scale commercial readiness. During his career, Dr. Dale has contributed his expertise to more than 100 projects including six approved commercial products in the United States and Europe. A tenured bacterial microbiologist and expert in both bacterial- and yeast-based fermentation, Dr. Dale has spearheaded numerous global R&D initiatives including the design, scale-up and implementation of fermentation processes for cGMP material; developed microbial systems at commercial scales of operation; and, has led collaboration efforts with third-party organizations for technology transfer of proven manufacturing processes.

Most recently, Dr. Dale served as Head of Microbial Technology for Basel, Switzerland-based Lonza where he led U.S. R&D efforts with a specific focus on bioprocess design, scale-up and technology transfer. Dr. Dale also served as Vice President of Technology for Cambrex Biopharma (which was ultimately acquired by Lonza), where he directed the Company's process development team to produce new, high-value service offerings for Cambrex customers. Previously, Dr. Dale held senior positions in manufacturing and process development for leading organizations including Covance Biotechnology Services, SmithKline Beecham Biologicals and the Centre for Biochemical Engineering at the University of Birmingham.

Dr. Dale holds a Ph.D. in Biochemistry from the University of Birmingham and a B.Sc. in Microbiology from the University of Wales. An accomplished scientist and thought leader, he was awarded the prestigious Cambridge Prize for outstanding research achievement and has published more than 40 publications. Dr. Dale currently serves on the editorial team of the Journal of Applied Biochemistry and Biotechnology and holds an editorial board seat for Bioprocess International.

About Qteros, Inc.

Qteros' mission is to accelerate the global commercialization of large-scale, lowest-cost cellulosic ethanol production. Qteros has teamed with a core group of world-class strategic partners that complement and leverage our advanced microbiology and process engineering expertise. Working closely with its strategic partners, Qteros expects to rapidly scale its highly efficient, lowest-cost Consolidated Bioprocessing (CBP) platform for converting non-food biomass into biofuels. Qteros is funded by leading investors in the alternative energy industry including, among others, Venrock Associates, Battery Ventures, BP AE Ventures, Soros Fund Management LLC, and Valero Energy Corporation. For more information, please visit www.qteros.com.

Contact:

Susan Hager

VP Corporate Communications & Government Affairs

[email protected]

(508) 251-6339

SOURCE Qteros, Inc.